DcR3 protects the development of autoimmune diabetes [91, 92], IgA nephropathy [93], and crescent glomerulonephritis [94] model mice, while DcR3-transgenic mice develop SLE-like syndrome [95]. Here, TNFRSF6B is linked to crescentic glomerulonephritis.